MSI status plus immunoscore to select metastatic colorectal cancer patients for immunotherapies
(2018) ESMO Immuno-Oncology Congress 2018 — Location: (Switzerland) Geneva (13.December.2018)
Files
2018_Galon_Ann_Oncol_12P.pdf
Open Access - Adobe PDF
- 77.76 KB
Details
- Authors
- Affiliations
Citations
Galon, J., Mlecnik, B., Hermitte, F., Marliot, F., Bifulco, C., Lugli, A., Nagtegaal, I. D., Hartmann, A., Van den Eynde, M., Roehrl, M., Ohashi, P., Zavadova, E., Torigoe, T., Patel, P., Wang, Y., Kawakami, Y., Marincola, F. M., Ascierto, P. A., Fox, B., & Pagès, F. (2018). MSI status plus immunoscore to select metastatic colorectal cancer patients for immunotherapies. Annals of Oncology, 29(Suppl 10), mdy493. https://doi.org/10.1093/annonc/mdy493.011 (Original work published 2018)